Composition
- Active ingredients
- ERTUGLIFLOZIN 15MG; SITAGLIPTIN PHOSPHATE EQ 100MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ERTUGLIFLOZIN 15MG; SITAGLIPTIN PHOSPHATE EQ 100MG BASE · TabletThis page
- ERTUGLIFLOZIN 5MG; SITAGLIPTIN PHOSPHATE EQ 100MG BASE · TabletNDA209805-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA209805.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Steglujan
- Active substance
- ertugliflozin
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- MSD Sub Merck
- Status
- Prescription
- FDA approval
- 19 Dec 2017
- Application
- NDA209805-002